Publikation

EGFR exon-level biomarkers of the response to bevacizumab-erlotinib in advanced non-squamous non-small cell lung cancer (NSCLC)

A translational substudy of SAKK 19/05

Konferenzpapier/Poster - 23.05.2012

Baty Florent